SCHEMBL12653216

SCHEMBL12653216

CC(C)Oc1ccccc1C(=O)c1cc(I)ccc1NC=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.45
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
RXFP1 Q9HBX9 2/20 0.40
ALDH1A1 P00352 2/20 0.40
ACHE P22303 1/20 0.40
KCNK3 O14649 2/20 0.39
KCNK9 Q9NPC2 2/20 0.39
BRPF1 P55201 5/20 0.39
HTR2A P28223 1/20 0.38
TSPO P30536 1/20 0.38
GPR183 P32249 1/20 0.38
APLNR P35414 1/20 0.38
MRGPRX1 Q96LB2 1/20 0.37
PRMT5 O14744 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12165535 0.86 IRAK4 (0.45) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL7088362 0.76 IRAK4 (0.72) IRAK4IDO1TDO2RXFP1ALDH1A1
SCHEMBL543548 0.71 TSHR (0.56) IRAK4RXFP1ALDH1A1ACHEMRGPRX1
SCHEMBL20496425 0.69 IRAK4 (0.58) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL20496480 0.69 IRAK4 (0.58) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL4020950 0.69 IRAK4 (0.42) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL4017686 0.69 ALDH1A1 (0.50) IRAK4IDO1TDO2ALDH1A1KDM4E
SCHEMBL12165506 0.68 TSHR (0.52) ALDH1A1LMNA
SCHEMBL27694472 0.67 IRAK4 (0.64) IRAK4IDO1TDO2ALDH1A1ACHE
SCHEMBL16453483 0.67 IRAK4 (0.68) IRAK4IDO1TDO2RXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011053697-A1 2-AMINOINDOLE COMPOUNDS AND METHODS FOR THE TREATMENT OF MALARIA GENZYME CORPORATION (US) 2011-05-05 WO disclosed